Form 8-K Sage Therapeutics, Inc. For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
SAGE Therapeutics (SAGE) Misses Q2 EPS by 22c
August 12, 2015 6:32 AM EDTSAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($0.90), $0.22 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
... More
